- Home
- CHT vs KVUE Comparison
CHT vs KVUE Comparison
Compare CHT & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHT
- KVUE
- Stock Information
- Founded
- CHT 1996
- KVUE 2022
- Country
- CHT Taiwan
- KVUE United States
- Employees
- CHT N/A
- KVUE N/A
- Industry
- CHT Telecommunications Equipment
- KVUE Specialty Chemicals
- Sector
- CHT Telecommunications
- KVUE Consumer Discretionary
- Exchange
- CHT Nasdaq
- KVUE Nasdaq
- Market Cap
- CHT 34.2B
- KVUE 40.9B
- IPO Year
- CHT 2003
- KVUE 2023
- Fundamental
- Price
- CHT $45.95
- KVUE $21.40
- Analyst Decision
- CHT
- KVUE Buy
- Analyst Count
- CHT 0
- KVUE 12
- Target Price
- CHT N/A
- KVUE $25.33
- AVG Volume (30 Days)
- CHT 128.8K
- KVUE 19.0M
- Earning Date
- CHT 08-05-2025
- KVUE 08-05-2025
- Dividend Yield
- CHT 2.81%
- KVUE 3.83%
- EPS Growth
- CHT 2.51
- KVUE N/A
- EPS
- CHT 0.15
- KVUE 0.55
- Revenue
- CHT $6,937,345,324.00
- KVUE $15,302,000,000.00
- Revenue This Year
- CHT $4.00
- KVUE $3.02
- Revenue Next Year
- CHT $1.19
- KVUE $3.52
- P/E Ratio
- CHT $31.66
- KVUE $38.79
- Revenue Growth
- CHT 3.08
- KVUE N/A
- 52 Week Low
- CHT $35.92
- KVUE $17.67
- 52 Week High
- CHT $46.33
- KVUE $25.17
- Technical
- Relative Strength Index (RSI)
- CHT 68.17
- KVUE 37.24
- Support Level
- CHT $45.80
- KVUE $21.12
- Resistance Level
- CHT $46.30
- KVUE $22.14
- Average True Range (ATR)
- CHT 0.47
- KVUE 0.56
- MACD
- CHT 0.10
- KVUE -0.08
- Stochastic Oscillator
- CHT 88.09
- KVUE 10.34
About CHT Chunghwa Telecom Co. Ltd.
Chunghwa Telecom Co Ltd is Taiwan's integrated telecom operator, providing fixed-line, wireless, and Internet and data services. The company segment consists of Consumer Business, Enterprise Business, International Business, and Others. The company generates the majority of its revenue from the Consumer Business segment. The consumer Business segment generates revenue from Mobile services, Fixed-line services, Sales, and others.
About KVUE Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.